← Back to Clinical Trials
Recruiting NCT05843890

NCT05843890 Tailored Pain Guide (TPG) Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05843890
Status Recruiting
Phase
Sponsor University of Michigan
Condition Chronic Lower Back Pain
Study Type INTERVENTIONAL
Enrollment 550 participants
Start Date 2023-08-18
Primary Completion 2028-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Structured and tailored PainGuideStandard PainGuide

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 550 participants in total. It began in 2023-08-18 with a primary completion date of 2028-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for chronic low back pain. This research will try to understand how much an electronic, self-management website like PainGuide can help participants. The study hypothesizes that tailored digital interventions (plus using PainGuide) will demonstrate greater improvement in pain interference.

Eligibility Criteria

Inclusion Criteria: * Chronic Lower Back pain (cLBP) defined by the National Institutes of Health (NIH) Task Force Report on Research Standards for Chronic Low Back Pain, (i.e., low back pain present at least six months, and present more than half of those days.) * Individuals must have a score of greater or equal to (≥) 60 on PROMIS Pain Interference. * Non-Pharma Sub-study: 1. Must be referred and currently on the waitlist for the NPP at the Back \& Pain Center (BPC) Exclusion Criteria: * Current cancer related pain * Diagnosis of autoimmune disease * Unable to speak, write or read English * Visual or hearing difficulties * Pregnancy or breastfeeding * Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.

Contact & Investigator

Central Contact

Beth Banner

✉ eledward@umich.edu

📞 734-998-5837

Principal Investigator

Daniel Clauw, MD

PRINCIPAL INVESTIGATOR

University of Michigan

Frequently Asked Questions

Who can join the NCT05843890 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Lower Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05843890 currently recruiting?

Yes, NCT05843890 is actively recruiting participants. Contact the research team at eledward@umich.edu for enrollment information.

Where is the NCT05843890 trial being conducted?

This trial is being conducted at Ann Arbor, United States.

Who is sponsoring the NCT05843890 clinical trial?

NCT05843890 is sponsored by University of Michigan. The principal investigator is Daniel Clauw, MD at University of Michigan. The trial plans to enroll 550 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology